plasminogen activator inhibitor type-1 纤溶酶原激活物抑制物 ; 型纤溶酶原激活物抑制剂
plasminogen activator inhibitor type-2 纤溶酶原激活剂抑制物型
plasminogen activator inhibitor type l 纤溶酶原激活物抑制物
human plasminogen-activator inhibitor type 人纤溶酶原激活物抑制物
plasma plasminogen activator inhibitor type- 血浆纤溶酶原激活物抑制物
plasminogen activator inhibitor type 1-1 纤溶酶原激活物抑制物
tissue plasminogen activator inhibitor type-1 纤溶酶原激活物抑制物
plasma plasminogen activator inhibitor type-1 血浆纤溶酶原激活物抑制物
type plasminogen activator inhibitor 纤溶酶原激活物抑制物
Objective to study the relationship between plasminogen activator inhibitor type 1 (PAI 1) and biological behaviour of hepatocellular carcinoma (HCC).
目的研究纤溶酶原激活物抑制剂(PAI1)与肝细胞癌(HCC)生物学特性的关系。
The researchers also found that plasminogen activator inhibitor type 2 (PAI2), a serine-protease inhibitor, inhibited proteolytic truncation of annexin-1 in macrophages infected with M. tuberculosis.
研究者还发现2型纤维蛋白溶酶原激活因子抑制物(PAI2)(一种丝氨酸蛋白酶抑制物)抑制结核杆菌感染的巨噬细胞内的膜联蛋白- 1的蛋白水解作用。
AIM: To observe the effect of extract of Ginkgo biloba leaves on plasminogen activator inhibitor 1(PAI-1)and thromboxane B2(TXB-2)in type 2 diabetes mellitus(DM).
目的：观察银杏叶提取物对2型糖尿病病人纤溶酶原激活物抑制物1（PAI 1）及凝血烷B2（TXB 2 ）的影响。
应用推荐